Flightpath Biosciences, Inc., a clinical stage biotechnology company focused on the development of precision therapeutics targeting bacterial ...

You've likely heard of the so-called "3-second rule." But is it a myth, or does it have a scientific basis? And does it apply ...

The glycerophosphodiesterase (GpdQ) from Enterobacter aerogenes is a promiscuous binuclear metallohydrolase that catalyzes the hydrolysis of mono-, di-, and triester substrates, including some ...

Analyzing the salinity parameter, a significant increase in total coliforms was observed during the rainy season. We identified the species Escherichia coli, Proteus mirabilis, Citrobacter freundii, ...

AbbVie has claimed FDA approval for Emblaveo, a new antibiotic product to treat complicated intra-abdominal infections (cIAI), including those caused by Gram-negative bacteria that represent a ...

Enterobacter species Enterobacter spp. are common Gram‐negative pathogens usually causing infections in immunocompromised, hospitalized patients and are well known for harbouring many antibiotic ...

Trends in AMR-related hospitalizations over the past decade were inconsistent and varied by causative pathogen, indicating the overall burden of AMR remains substantial.

Over the past few decades, human activities have accelerated the rates and extents of water eutrophication and global warming through increasing delivery of biologically available nitrogen such as ...

Plasmid mediated AmpC β -lactamases has arisen through the transfer of chromosomal genes for the inducible AmpC β -lactamases on to plasmids. This transfer has resulted in plasmid mediated AmpC β ...